Clinical Trial Update: A Study of Rabeprazole for Prevention of Non Steroidal Anti-inflammatory Drug -Associated Gastroduodenal Injury [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating rabeprazole to prevent NSAID-associated gastroduodenal injury in patients with osteoarthritis or rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspepsia
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Rabeprazole (rabeprazole)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Osteoarthritis, Arthritis, Rheumatoid | Phase 3 | Status: COMPLETED